Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 2, 1998

View Archived Issues

Abbott synthesizes a novel series of cyclic antifungal agents

Akzo Nobel describes new gonadotropins with therapeutic potential

Alcon discloses new antiglaucoma agents in patent literature

New antifungals from Lilly

New anticoagulants reported by Berlex

Canadian researchers design new cysteine protease inhibitors

Anti-MRSA agents prepared at Bristol-Myers Squibb

Warner-Lambert describes water-soluble, nonpeptide ET antagonists

New class of orally active bradykinin B2 antagonists presented by Fujisawa

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Avakine submitted for FDA review

CIMA terminates one and initiates another OraSolv agreement

VX-740 advances in preclinical studies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...